Alexion To Pay $10M To Settle Patent Lawsuit

Law360, New York (February 19, 2008, 12:00 AM EST) -- Alexion Pharmaceuticals Inc. has agreed to pay $10 million to the Oklahoma Medical Research Foundation to settle a patent dispute related to the drug Soliris.

Under the settlement, Alexion will pay $10 million in order to acquire all rights and interests to the patents at issue, making payments over the remainder of 2008 and 2009. The ongoing litigation will be dismissed.

Alexion's Soliris drug was approved by the FDA to treat a rare blood disorder, paroxysmal nocturnal humoglobinuria, or PNH, which strikes one in a million...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.